Study Evaluating TTI-237 in Advanced Malignant Solid Tumors
Clinical trial NCT00195247 · TERMINATED
Trial details
- NCT number
- NCT00195247
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.